David Carballo
Overview
Explore the profile of David Carballo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gkotsoulia C, Tacchini V, Barrier A, Guijarro D, Adamopoulos D, Poku N, et al.
Rev Med Suisse
. 2025 Jan;
21(903):190-195.
PMID: 39881645
The year 2024 has seen significant progress in the management of heart failure. New treatments have demonstrated their efficacy, particularly for heart failure with preserved ejection fraction, cardiac amyloidosis, and...
2.
Boudon A, Locatelli I, Gencer B, Carballo D, Klingenberg R, Raber L, et al.
BMJ Open
. 2025 Jan;
15(1):e088262.
PMID: 39819911
Objectives: To assess the association between the intensity of statin therapy and the level of physical activity in patients 1 year after an acute coronary syndrome (ACS). Design: Prospective cohort...
3.
Johner N, Branca M, Carballo D, Baggio S, Nanchen D, Tessitore E, et al.
Eur J Prev Cardiol
. 2024 Oct;
PMID: 39454630
Aims: The benefit of long-term beta-blocker therapy after acute coronary syndromes (ACS) without heart failure in the reperfusion era is uncertain. Two recent randomized trials found conflicting results. The present...
4.
Follonier C, Rabassa G, Branca M, Carballo D, Koskinas K, Heg D, et al.
Atheroscler Plus
. 2024 Oct;
58:1-8.
PMID: 39351317
Background And Aims: The 2019 European Society of Cardiology guidelines for the management of dyslipidemia consider the use of high-dose marine omega-3 fatty acid (FA) eicosapentaenoic acid (EPA) supplementation (icosapent...
5.
Krasieva K, Gencer B, Locatelli I, Carballo D, Muller O, Fournier S, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Jun;
17(8):e010790.
PMID: 38899458
Background: Long-term control of cardiovascular risk factors after acute coronary syndrome (ACS) is the cornerstone for preventing recurrence. We investigated the extent of cardiovascular risk factor management in males and...
6.
Massie E, Dominati A, Suchet S, Carballo D, Hervier E, Fokstuen S, et al.
Eur Heart J Case Rep
. 2024 Jun;
8(4):ytae160.
PMID: 38887779
Background: Desmoplakin cardiomyopathy has been recently classified as a non-dilated left ventricular cardiomyopathy, which is characterized by inflammatory-like episodes followed by left ventricular fibrosis/dysfunction and ventricular arrhythmias. Specific management is...
7.
Holtrop J, Bhatt D, Ray K, Mach F, Smulders Y, Carballo D, et al.
Eur J Prev Cardiol
. 2024 Feb;
31(6):754-762.
PMID: 38324720
Aims: This study aimed to evaluate the stepwise approach for cardiovascular (CV) risk factor treatment as outlined by the European Society for Cardiology 2021 guidelines on CV disease (CVD) prevention...
8.
Tessitore E, Branca M, Heg D, Nanchen D, Auer R, Raber L, et al.
Eur J Prev Cardiol
. 2023 Nov;
31(7):845-855.
PMID: 37995305
Aims: To evaluate the risk of alcohol consumption after acute coronary syndromes (ACS). Methods And Results: A total of 6557 patients hospitalized for ACS at four Swiss centres were followed...
9.
Koskinas K, Twerenbold R, Carballo D, Matter C, Cook S, Heg D, et al.
Front Cardiovasc Med
. 2023 Oct;
10:1203427.
PMID: 37900573
Background: Although the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) causing coronavirus disease 2019 (COVID-19) primarily affects the respiratory system, the disease entity has been associated with cardiovascular complications. This...
10.
Jolti M, Darbellay Farhoumand P, Carballo D, Carballo S
Rev Med Suisse
. 2023 Oct;
19(847):2002-2006.
PMID: 37878100
Acute heart failure is a leading cause of hospitalisations with an increasing economic and public health burden. Management of acute heart failure involves the use of diuretics to treat congestion...